Published in J Clin Invest on January 01, 1961
STUDIES ON DIGITALIS. IX. EFFECTS OF OUABAIN ON THE NONFAILING HUMAN HEART. J Clin Invest (1963) 1.46
The effects of acute hypoxia on the systemic venous and arterial systems and on myocardial contractile force. J Clin Invest (1962) 1.27
Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside. J Clin Invest (1971) 1.19
Studies on digitalis. XVI. Effects on myocardial oxygen consumption. J Clin Invest (1966) 1.17
Effect of various fluid regimens and pharmacologic agents on the circulatory hemodynamics of the immediate postburn period. Ann Surg (1966) 1.09
The role of inotropic variation in ventricular function during atrial fibrillation. J Clin Invest (1970) 1.02
[Coronary reserve capacity and maximum oxygen consumption of the human heart]. Basic Res Cardiol (1973) 0.89
Digoxin for heart failure in sinus rhythm. Thorax (1979) 0.87
The heart and digitalis. Br Med J (1963) 0.83
Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris. Br Heart J (1972) 0.83
The effect of chronic digitoxin administration on the contractile state of normal and nonfailing hypertrophied myocardium. J Clin Invest (1975) 0.81
Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog. J Clin Invest (1974) 0.80
Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure. J Clin Invest (1976) 0.79
New concepts of digitalis. Calif Med (1969) 0.78
Effects of digoxin on muscle reflexes in normal humans. Eur J Appl Physiol (2009) 0.77
Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a noninvasive study. Br J Clin Pharmacol (1988) 0.75
Effect of Intravenous Digoxin on Blood Pressure, Serum Electrolytes, Renal Hemodynamics and Excretory Function in Normal and Hypertensive Subjects, and Subjects in Congestive Heart Failure. Can Med Assoc J (1961) 0.75
The relation of potassium to digitalis effectiveness and toxicity. Calif Med (1963) 0.75
The role of digitalis in the future. Br J Clin Pharmacol (1984) 0.75
Digitalis in pneumonectomy and its implication. J Natl Med Assoc (1979) 0.75
Nonocclusive hemorrhagic necrosis of the intestine. West J Med (1974) 0.75
THE EFFECT OF DIGITALIS ON THE CARDIAC OUT-PUT OF DOGS AND ITS BEARING ON THE ACTION OF THE DRUG IN HEART DISEASE. J Clin Invest (1926) 8.64
Ventricular function. I. Starling's law of the heart studied by means of simultaneous right and left ventricular function curves in the dog. Circulation (1954) 5.23
THE CIRCULATORY CHANGES AFTER FULL THERAPEUTIC DOSES OF DIGITALIS, WITH A CRITICAL DISCUSSION OF VIEWS ON CARDIAC OUTPUT. J Clin Invest (1930) 4.49
THE RELATION BETWEEN CARDIAC SIZE AND CARDIAC OUTPUT PER MINUTE FOLLOWING THE ADMINISTRATION OF DIGITALIS IN NORMAL DOGS. J Clin Invest (1928) 3.41
Some effects of digoxin upon the heart and circulation in man; digoxin in chronic cor pulmonale. Circulation (1950) 3.09
THE EFFECTS OF THE CARDIAC GLYCOSIDES UPON THE DYNAMICS OF THE CIRCULATION IN CONGESTIVE HEART FAILURE. I. OUABAIN. J Clin Invest (1948) 2.02
Effect of strophanthus on coronary blood flow and cardiac oxygen consumption of normal and failing human hearts. Circulation (1950) 1.86
Resistance strain gauge arches for direct measurement of heart contractile force in animals. Proc Soc Exp Biol Med (1953) 1.66
Comparative heart contractile force effects of equipressor doses of several sympathomimetic amines. J Pharmacol Exp Ther (1953) 1.65
Direct measurement of changes in cardiac contractile force; relationship of such measurements to stroke work, isometric pressure gradient and other parameters of cardiac function. Am J Physiol (1956) 1.62
Studies on digitalis. I. Direct effects on peripheral vascular resistance. J Clin Invest (1960) 1.57
Some effects of digoxin on the heart and circulation in man; digoxin in enlarged hearts not in clinical congestive failure. Circulation (1951) 1.46
Action of digitalis on the nonfailing heart of the dog. Am J Physiol (1958) 1.33
Studies on digitalis. II. Extracardiac effects on venous return and on the capacity of the peripheral vascular bed. J Clin Invest (1960) 1.20
Myocardial metabolism in congestive heart failure. J Chronic Dis (1959) 1.19
Hemodynamic effects of cardiac glycosides on normal human subjects during rest and exercise. J Appl Physiol (1958) 1.18
A newly modified electromagnetic blood flowmeter capable of high fidelity flow registration. Circulation (1952) 1.16
Comparative increase in ventricular contractile force produced by several cardiac glycosides. J Pharmacol Exp Ther (1950) 1.13
Efect of digoxin on the circulation in normal man. Br Heart J (1959) 1.06
The influence of cardiopulmonary bypass with cardiac arrest and right ventriculotomy on myocardial contractile force. Ann Surg (1958) 0.98
Myocardial contractility in man: The acute effects of digitalis, sympathomimetic amines, and anoxic cardiac arrest. Surg Forum (1960) 0.95
Effects of lanatoside C on cardiovascular hemodynamics; acute digitalizing doses in subjects with normal hearts and with heart disease without failure. Am J Cardiol (1959) 0.94
Contractility of actomyosin bands prepared from normal and failing human hearts. J Clin Invest (1958) 0.86
[Studies of hepatic output in humans: changes in hepatic blood flow caused by digitalis]. Cuore Circ (1957) 0.84
Surgical management of aneurysms of the ascending aorta. Including those associated with aortic valvular incompetence. Surg Clin North Am (1966) 6.84
Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev (1972) 5.07
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol (1969) 2.53
Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther (1966) 2.52
Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation (1972) 2.49
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther (1969) 2.11
The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis. Circulation (1966) 1.97
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Dopamine--clinical uses of an endogenous catecholamine. N Engl J Med (1974) 1.89
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Causes of early postoperative death following cardiac valve replacement. Clinico-pathologic correlations in 64 patients studied at necropsy. J Thorac Cardiovasc Surg (1967) 1.78
Dopamine in the treatment of hypotension and shock. N Engl J Med (1966) 1.77
Definitive surgical treatment of anomalous origin of left coronary artery from pulmonary artery: indications and results. J Thorac Cardiovasc Surg (1966) 1.71
The potential role of dopamine in the treatment of shock. Prog Cardiovasc Dis (1969) 1.70
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
Cardiac transplantation for advanced acquired heart disease. J Cardiovasc Surg (Torino) (1969) 1.62
Influence of right atrial pressure pulse on instantaneous vena caval blood flow. Am J Physiol (1966) 1.58
Prosthetic replacement of the mitral valve. Preoperative and postoperative clinical and hemodynamic assessments in 100 patients. Circulation (1967) 1.58
Pseudoaneurysm of the left ventricle. An unusual sequel of myocardial infarction and rupture of the heart. Am J Med (1967) 1.57
Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes. Crit Care Med (1994) 1.53
Operative treatment in idiopathic hypertrophic subaortic stenosis. Techniques, and the results of preoperative and postoperative clinical and hemodynamic assessments. Circulation (1968) 1.50
Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation (1975) 1.49
Operative treatment of atrial septal defect: clinical and haemodynamic assessments in 175 patients. Br Heart J (1967) 1.47
Obstruction to left ventricular outflow. Current concepts of management and operative treatment. Ann Intern Med (1968) 1.47
Transplantation of the human heart. Report of four cases. JAMA (1968) 1.46
Pathologic anatomy of cardiac valve replacement: a study of 224 necropsy patients. Prog Cardiovasc Dis (1973) 1.46
Calcific pulmonic stenosis. Circulation (1968) 1.43
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA (1970) 1.43
A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol (1978) 1.41
Acute severe mitral regurgitation secondary to ruptured chordae tendineae: clinical, hemodynamic, and pathologic considerations. Circulation (1966) 1.39
Mechanism of obstruction of the infradiaphragmatic portion of the inferior vena cava in the presence of increased intra-abdominal pressure. Invest Radiol (1966) 1.39
Organ transplantation for advanced cardiopulmonary disease. Ann Thorac Surg (1969) 1.38
Coronary arterial-right heart fistulae. Long-term observations in seven patients. Circulation (1973) 1.37
Ultrastructure of crista supraventricularis muscle in patients with congenital heart diseases associated with right ventricular outflow tract obstruction. Circulation (1975) 1.33
The flexible stent. A new concept in the fabrication of tissue heart valve prostheses. J Thorac Cardiovasc Surg (1971) 1.33
Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation (1978) 1.33
Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. Prog Cardiovasc Dis (1977) 1.32
The influence of atrial contraction and mitral valve mechanics on ventricular filing. A study of instantaneous mitral valve flow in vivo. Am Heart J (1969) 1.28
The use of quaternary narcotic antagonists in opiate research. Neuropharmacology (1985) 1.27
Pressure-flow relationships in the ascending aorta and femoral artery of man. J Appl Physiol (1965) 1.25
The effects of epicardiectomy on the performance of the acutely ischemic left ventricle. J Thorac Cardiovasc Surg (1968) 1.23
Effects of dopamine on isolated canine coronary arteries. Cardiovasc Res (1975) 1.23
Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation (1966) 1.23
Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation (1980) 1.22
Open heart surgery without blood transfusion. Arch Surg (1967) 1.21
Effects of heart rate on the dynamics of force development in the intact human ventricle. Circulation (1966) 1.19
Cholesterol pericarditis. Considerations of its pathogenesis and treatment. Am J Med (1966) 1.18
Clinical experience in transplantation of the human heart: report of ten cases. Transplant Proc (1969) 1.18
Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther (1984) 1.17
Carotid endarterectomy without a shunt. Results using hypercarbic general anesthesia to prevent cerebral ischemia. Arch Surg (1968) 1.16
Tissue ingrowth and the rigid heart valve. Review of clinical and experimental experience during the past year. J Thorac Cardiovasc Surg (1968) 1.16
Giant right atrium in rheumatic mitral stenosis. Atrial enlargement restricted by mural calcification. Am Heart J (1970) 1.16
The effects of morphine on the resistance and capacitance vessels of the peripheral circulation. Am Heart J (1966) 1.15
Mechanisms of action of morphine in the treatment of experimental pulmonary edema. Am J Cardiol (1966) 1.15
Tricuspid regurgitation. A comparison of nonoperative management, tricuspid annuloplasty, and tricuspid valve replacement. J Thorac Cardiovasc Surg (1976) 1.15
Atrioventricular valve replacement with the Hancock porcine xenograft: a five year clinical experience. Surgery (1975) 1.15
Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J (1982) 1.14
A hemodynamic comparison of dopamine and isoproterenol in patients in shock. Circulation (1969) 1.14
Mechanical destruction of erythrocytes by incompetent aortic valvular prosthesis; clinical, hemodynamic, and hematologic findings. Am Heart J (1966) 1.13
Congenital aortic stenosis resulting from a unicommisssural valve. Clinical and anatomic features in twenty-one adult patients. Circulation (1971) 1.13
Congenitally bicuspid aortic valve causing severe, pure aortic regurgitation without superimposed infective endocarditis. Analysis of 13 patients requiring aortic valve replacement. Am J Cardiol (1981) 1.13
Aneurysm of the ascending aorta with aortic valvular insufficiency. Surgical management. Arch Surg (1966) 1.13
Effects of dopamine on renal function and hemodynamics in the dog. J Pharmacol Exp Ther (1967) 1.12
Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing. Ann Intern Med (1967) 1.12
Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg (1978) 1.12
Sodium nitroprusside treatment of ergotamine-induced peripheral ischemia. JAMA (1974) 1.11
Use of sympathomimetic amines in heart failure. Am J Cardiol (1968) 1.11
An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine. J Pharmacol Exp Ther (1968) 1.11
Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation (1967) 1.10
Closure of the calcified patent ductus. A new operative method utilizing cardiopulmonary bypass. J Thorac Cardiovasc Surg (1966) 1.10
Tunnel subaortic stenosis: left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation (1976) 1.10
Ventriculo-atrial regurgitation following prosthetic replacement of the mitral valve. Angiocardiographic and hemodynamic findings. Am J Cardiol (1966) 1.10
Attenuation of dopamine-induced renal vasodilation in the dog by phenothiazines. Eur J Pharmacol (1971) 1.09
Aortic valve replacement in the elderly. Encouraging postoperative clinical and hemodynamic results. Arch Surg (1977) 1.09
Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol (1983) 1.07
Clinical and hemodynamic assessments of fabric-covered Starr-Edwards prosthetic valves. J Thorac Cardiovasc Surg (1970) 1.06
Two-stage surgical treatment of ventricular septal defect: results of pulmonary artery banding in infants and subsequent open-heart repair. J Thorac Cardiovasc Surg (1966) 1.05
Gamma-globulin in the prophylaxis of posttransfusion hepatitis. JAMA (1966) 1.05
Experimental tricuspid valve replacement. Evaluations of anticoagulants and graphite-benzalkonium-heparin coating. J Thorac Cardiovasc Surg (1966) 1.05
Isolated hypertrophic obstruction to right ventricular outflow. Clinical, hemodynamic, and angiographic findings before and after operative treatment. Am Heart J (1969) 1.04
Aortico-left ventricular tunnel. A cause of massive aortic regurgitation and of intracardiac aneurysm. Am J Med (1965) 1.04
Seroepidemiological studies of transfusion-associated hepatitis. J Infect Dis (1971) 1.03
Aortic valve replacement without myocardial revascularization in patients with combined aortic valvular and coronary artery disease. Circulation (1981) 1.03
Total cardiac valve replacement using SCDK-cutter prosthesis: experience with 250 consecutive patients. Ann Surg (1966) 1.03
Dopamine receptors: applications in clinical cardiology. Circulation (1985) 1.03
Experimental endocarditis following cardiac valve replacement. Evaluation of cloth-covered valves and the role of antibiotics. J Thorac Cardiovasc Surg (1970) 1.02
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Echocardiographic and gross anatomic findings. Circulation (1974) 1.02
Human heart transplantation. Experience with twelve cases. Am J Cardiol (1968) 1.02
Experimental evaluation of pentazocine: effect on myocardial contractility and peripheral vascular resistance. Am Heart J (1971) 1.02
Late postoperative pathological findings after cardiac valve replacement. Circulation (1967) 1.02
Hemodynamic abnormalities in response to mild and intense upright exercise following operative correction of an atrial septal defect or tetralogy of Fallot. Circulation (1973) 1.02
Results of valve replacement for severe mitral regurgitation due to papillary muscle rupture or fibrosis. Am J Cardiol (1973) 1.02
Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J (1983) 1.01
Evaluation of right atrial-pulmonary artery conduits for tricuspid atresia. Experimental study. J Thorac Cardiovasc Surg (1979) 1.01
Current results of operation for mitral stenosis. Clinical and hemodynamic assessments in 124 consecutive patients treated by closed commissurotomy, open commissurotomy, or valve replacement. Circulation (1972) 1.00
Recent advances in the pharmacology of catecholamines. Intensive Care Med (1977) 1.00
Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene. Nature (1976) 1.00
Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system? Commun Psychopharmacol (1979) 1.00